AU Patent

AU2001268710A1 — Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy

Assigned to Bristol Myers Squibb Pharma Co · Expires 2002-01-02 · 24y expired

What this patent protects

Patent listed against bendamustine-hydrochloride.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2001268710A1
Jurisdiction: AU
Classification: —
Expires: 2002-01-02
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Pharma Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.